Clinical-stage biotech developing structurally engineered fatty acid therapeutics.
| Date | Round | Amount |
|---|---|---|
| Dec 2021 | Series C Amsterdam biotech NorthSea Therapeutics raised USD 80M in Series C co-led by Ysios Capital and Forbion Growth to advance its NASH and metabolic disorder pipeline. | $80M |